Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine

Open Forum Infectious Diseases
Amy Parker FiebelkornSteven Rubin

Abstract

Mumps outbreaks in populations with high 2-dose measles-mumps-rubella (MMR) vaccine coverage raise the question whether a third dose of MMR vaccine (MMR3) is needed. However, data on the immunogenicity of MMR3 are limited. We assessed mumps virus neutralizing antibody levels pre- and post-MMR3 in a nonoutbreak setting. Mumps antibody titers were assessed at baseline, 1 month, and 1 year after MMR3 in subjects aged 18-28 years. At baseline, 5 of 656 (0.8%) subjects had seronegative mumps neutralizing antibody titers and 38 (5.8%) had low titers. One year post-MMR3, these numbers declined to 3 (0.5%) and 16 (2.4%), respectively. Subjects with low baseline titers were more likely to have low 1-month and 1-year titers (R (2) = 0.81-0.87, P < .0001). Compared to baseline, geometric mean titers were significantly higher at 1 month (P < .0001) and 1 year (P < .01) post-MMR3; however, reverse cumulative distribution curves showed only minimal shifts in mumps titers from baseline to 1 month and 1 year. Very few subjects had negative or low baseline mumps titers. Nonetheless, mumps titers had modest but significant increases when measured 1 month and 1 year post-MMR3. This temporary increase in titers could decrease susceptibility to dis...Continue Reading

References

Aug 1, 1991·The Journal of Pediatrics·B S HershC L Wood
Jan 13, 1989·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control (CDC)
Dec 1, 1988·The Journal of Infectious Diseases·M WhartonW Schaffner
Dec 1, 1981·Journal of Virological Methods·P AlbrechtG R Burns
Jul 1, 1995·Archives of Pediatrics & Adolescent Medicine·J E CheekR D Crider
Mar 4, 1999·Bulletin of the World Health Organization·A M GalazkaA Kraigher
Apr 24, 2004·The Journal of Infectious Diseases·Samuel L Katz, Alan R Hinman
Sep 26, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Susan E Reef, Stephen L Cochi
Mar 7, 2007·Archives of Pediatrics & Adolescent Medicine·Charles W LeBaronPaul Gargiullo
Mar 21, 2007·Emerging Infectious Diseases·Cheryl CohenMary E Ramsay
Oct 3, 2007·Pediatrics·Joshua K SchaffzinPerry Smith
Apr 12, 2008·The New England Journal of Medicine·Gustavo H DayanJane F Seward
Dec 31, 2008·The Journal of Infectious Diseases·Charles W LeBaronBradley J Sullivan
Feb 14, 2009·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·C RobertsJ Hart
Aug 8, 2009·The Journal of Infectious Diseases·Charles W LeBaronBradley J Sullivan
Oct 8, 2009·The Medical Journal of Australia·Revle D Bangor-JonesMary M Whitty
May 13, 2010·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·J WhelanS Hahné
May 18, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Shelley L DeeksNatasha S Crowcroft
Sep 22, 2011·The Journal of Infectious Diseases·Margaret M CorteseSteven Rubin
Oct 1, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·UNKNOWN Centers for Disease Control and Prevention
Nov 7, 2012·Pediatrics·Ikechukwu U OgbuanuKathleen Gallagher
Aug 3, 2013·Western Pacific Surveillance and Response Journal : WPSAR·Igore MunkhjargalDapeng Luo
Dec 29, 2013·Clinical and Vaccine Immunology : CVI·Donald R LatnerCarole J Hickman

❮ Previous
Next ❯

Citations

Sep 13, 2015·Vaccine·Eduardo Santacruz-SanmartínFrancisco J Díaz
Apr 21, 2016·The Pediatric Infectious Disease Journal·Steven RubinGregory Poland
Jul 29, 2016·MMWR. Morbidity and Mortality Weekly Report·Justin P AlbertsonFredrick Echols
Apr 14, 2016·Central European Journal of Public Health·Martina HavlíčkováVilma Marešová
May 12, 2017·Clinical and Vaccine Immunology : CVI·Xin-Xing GuChristopher E Taylor
Jan 1, 2019·Uirusu·Minoru Kidokoro
Sep 12, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nakia S ClemmonsAmy Parker Fiebelkorn
May 22, 2019·The Journal of Infectious Diseases·Patricia KaaijkRob S van Binnendijk
Sep 27, 2018·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Lamprini VenetiØystein Rolandsen Riise
Sep 4, 2019·Journal of American College Health : J of ACH·Mariel MarlowMona Marin
Sep 7, 2017·The New England Journal of Medicine·Cristina V CardemilPatricia Quinlisk
May 3, 2018·Journal of the Pediatric Infectious Diseases Society·Stanley A Plotkin
Sep 5, 2019·Proceedings of the National Academy of Sciences of the United States of America·Mohammed Ata Ur RasheedSrilatha Edupuganti
Feb 28, 2020·Clinical Microbiology Reviews·Eugene LamJane R Zucker
Sep 27, 2018·International Journal of Environmental Research and Public Health·Hong PangQingwu Jiang
Aug 2, 2018·International Journal of Environmental Research and Public Health·Andrea-Ioana Beleni, Stefan Borgmann
May 14, 2020·BMC Public Health·Mpho Lerato SikhosanaNkengafac Villyen Motaze
Aug 9, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mona MarinHuong Q McLean
Jun 8, 2021·Expert Review of Vaccines·Florence KauffmannGiacomo Casabona
Mar 23, 2018·Science Translational Medicine·Joseph A Lewnard, Yonatan H Grad

❮ Previous
Next ❯

Methods Mentioned

BETA
serum collection

Software Mentioned

SigmaPlot

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.